Paul Tudor Jones Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Tudor Investment Corp Et Al

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $63,666 - $87,888	-300 Reduced 17.65%	1,400 $297,000
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $96,665 - $145,995	500 Added 41.67%	1,700 $476,000
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $205,644 - $339,876	1,200 New	1,200 $320,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.